InventisBio Co., Limited

¥13.68As of Sun 8 Nov 2026, 12:00 UTC
SSE:688382Healthcare
Country China
PE (Fwd) •••
TSR 4Y CAGR (2.69%)
Div yield —
ROE (25.45%)
Biotechnology
Beta (5Y) 0.46
PE TTM —
TSR TTM (54.85%)
Mkt cap ¥7.929B
ROIC (16.67%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥17
22.22%
(38.94%)
Sell 3|7|7|7|12
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.13
0.13
0.14
0.14
7.00%
13.82%
15.01%
20.88%
Revenue¥M
377.4
376.4
396.1
387.5
5.00%
1.09%
4.39%
2.35%
Peers (US$1.189B)
Cap (US$)
PE
1.199B
72.64x
1.128B
50.13x
Capital
TTM
5Y
10Y
Leveragex
5.508
—
—
EBIT/Intx
0.153
0.357
0.307
Own earn%
46.54
31.44
29.01
Sh yield%
26.78
22.11
22.85
Owners
Insiders/Inst%
4.75
41.21
Short interest%
2.22
SBC / revenue%
1.90
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
17–24
$1 testx
—
Incr. ROIC%
91